Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg∈26 mice

被引:124
作者
Veltkamp, C
Tonkonogy, SL
De Jong, YP
Albright, C
Grenther, WB
Balish, E
Terhorst, C
Sartor, RB
机构
[1] Univ N Carolina, Sch Med, Dept Med, Div Digest Dis & Nutr,Ctr GI Biol & Dis, Chapel Hill, NC 27599 USA
[2] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA
[3] Beth Israel Hosp, Div Immunol, Boston, MA USA
[4] Univ Wisconsin, Dept Surg, Madison, WI USA
[5] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI USA
关键词
D O I
10.1053/gast.2001.22547
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Normal resident bacteria are required for development of colitis in several rodent models. We determined whether bacterial stimulation is necessary for both induction and perpetuation of mucosal inflammation and T-cell activation in Tg epsilon 26 mice, in which transplantation of wild-type bone marrow (BM double right arrow Tg epsilon 26) causes colitis under specific pathogen-free (SPF) conditions. Methods: BM from (C57BL/6 X CBA/J) Fl mice was transplanted into germfree (GF) or SPF Tg epsilon 26 mice. Mesenteric lymph node (MLN) cells from these mice were then transferred into SPF or GF recipients. Colitis and activation of MLN cells were measured by histologic scores, membrane marker analysis, and intracellular cytokine staining. Cytokine secretion by MLN cells stimulated by anti-CD3 or by luminal or epithelial antigens was measured by ELISA. Results: Colitis did not develop when BM was transferred into GF recipient mice (BM double right arrow GF Tg epsilon 26). T lymphocytes that secreted interferon gamma upon activation were present in the MLN of BM double right arrow GF Tg epsilon 26 mice, albeit in lower frequency than in control BM double right arrow SPF Tg epsilon 26 mice, Furthermore, transfer of MLN cells from BM double right arrow SPF Tg epsilon 26 mice into SPF Tg epsilon 26 recipients induced active colitis, but not if the same cells were transferred into GF Tg epsilon 26 recipients. Although CD4 T cells were detected in the colonic mucosa of GF recipients, no inflammation was observed for at least 31 weeks. In a reciprocal experiment, MLN cells from BM double right arrow GF Tg epsilon 26 mice without colitis transferred disease to SPF Tge26 recipients within 2-4 weeks. Conclusions: Activated T cells are present in the mucosa of BM double right arrow GF Tg epsilon 26 mice but are incapable of inducing disease unless colonic bacteria are present. Moreover, pathogenic T cells require the continuous presence of colonic bacteria to sustain colitis.
引用
收藏
页码:900 / 913
页数:14
相关论文
共 48 条
[1]  
Aranda R, 1997, J IMMUNOL, V158, P3464
[2]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[3]   Effects of antibiotics on the initiation and perpetuation of colitis in the IL-10 KO mice. [J].
Braat, H ;
Dieleman, LA ;
Sellon, RK ;
Schultz, M ;
Sartor, RB .
GASTROENTEROLOGY, 1998, 114 (04) :A940-A940
[4]   THE INTESTINAL AND SERUM HUMORAL IMMUNE-RESPONSE OF MICE TO SYSTEMICALLY AND ORALLY-ADMINISTERED ANTIGENS IN LIPOSOMES .1. THE RESPONSE TO LIPOSOME-ENTRAPPED SOLUBLE-PROTEINS [J].
CLARKE, CJ ;
STOKES, CR .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 32 (1-2) :125-138
[5]  
CONG BY, 1999, IMMUNOL LETT, V69, P117
[6]   CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].
Cong, YZ ;
Brandwein, SL ;
McCabe, RP ;
Lazenby, A ;
Birkenmeier, EH ;
Sundberg, JP ;
Elson, CO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864
[7]   T helper cell 1-type CD4(+) T cells, but not B cells, mediate colitis in interleukin 10-deficient mice [J].
Davidson, NJ ;
Leach, MW ;
Fort, MM ;
ThompsonSnipes, L ;
Kuhn, R ;
Muller, W ;
Berg, DJ ;
Rennick, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :241-251
[8]  
Dianda L, 1997, AM J PATHOL, V150, P91
[9]  
Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448
[10]  
Ehrhardt RO, 1997, J IMMUNOL, V158, P566